1404. A Pharmacokinetic Study on CMS and Colistin and Its Impact on Clinical Cure and Acute Kidney Injury in Critically Ill Patients with Normal Renal Function from South India

BACKGROUND: Colistin has re-emerged as last line antimicrobial to combat MDR GNB. There is need for robust pharmacokinetic (PK) and pharmacodynamics (PD) data to guide dosing. This study assessed the PK of CMS and colistin and its impact on clinical cure (CC) and acute kidney injury (AKI) in critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Vidya, Sudhir, Sangita, Moni, Merlin, Ts, Dipu, Mohammed, Zubair, Balachandran, Sabarish, Singh, Sanjeev, Patel, Payal, Kaye, Keith S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253820/
http://dx.doi.org/10.1093/ofid/ofy210.1235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253820/
http://dx.doi.org/10.1093/ofid/ofy210.1235

Ejemplares similares